Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Bristol Myers Squibb (NYSE: BMY) has announced its participation in two major investor conferences in March 2025. The company will engage in a fireside chat at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 2:30 p.m. ET. Additionally, BMY will participate in another fireside chat at the Leerink Partners 2025 Global Healthcare Conference on March 12, 2025, at 11:20 a.m. ET.
Both investors and the general public are invited to listen to these sessions by visiting the company's investor relations website at http://investor.bms.com. For those unable to attend live, archived recordings of each session will be made available after their conclusion.
Bristol Myers Squibb (NYSE: BMY) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel marzo 2025. L'azienda parteciperà a una chiacchierata informale durante il TD Cowen 45° Annual Health Care Conference il 4 marzo 2025, alle 14:30 ET. Inoltre, BMY parteciperà a un'altra chiacchierata informale al Leerink Partners 2025 Global Healthcare Conference il 12 marzo 2025, alle 11:20 ET.
Sia gli investitori che il pubblico generale sono invitati ad ascoltare queste sessioni visitando il sito web delle relazioni con gli investitori dell'azienda all'indirizzo http://investor.bms.com. Per coloro che non possono partecipare dal vivo, saranno disponibili registrazioni archiviate di ciascuna sessione dopo la loro conclusione.
Bristol Myers Squibb (NYSE: BMY) ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025. La compañía participará en una charla informal en el TD Cowen 45ª Conferencia Anual de Atención Médica el 4 de marzo de 2025, a las 2:30 p.m. ET. Además, BMY participará en otra charla informal en la Leerink Partners 2025 Conferencia Global de Atención Médica el 12 de marzo de 2025, a las 11:20 a.m. ET.
Tanto los inversores como el público en general están invitados a escuchar estas sesiones visitando el sitio web de relaciones con inversores de la compañía en http://investor.bms.com. Para aquellos que no puedan asistir en vivo, se pondrán a disposición grabaciones archivadas de cada sesión después de su conclusión.
Bristol Myers Squibb (NYSE: BMY)는 2025년 3월에 두 개의 주요 투자자 회의에 참석할 것이라고 발표했습니다. 이 회사는 2025년 3월 4일 오후 2시 30분 ET에 TD Cowen 제45회 연례 의료 회의에서 파이어사이드 챗에 참여할 예정입니다. 또한, BMY는 2025년 3월 12일 오전 11시 20분 ET에 Leerink Partners 2025 글로벌 의료 회의에서 또 다른 파이어사이드 챗에 참여합니다.
투자자와 일반 대중은 http://investor.bms.com에서 회사의 투자자 관계 웹사이트를 방문하여 이러한 세션을 들을 수 있습니다. 실시간으로 참석할 수 없는 분들을 위해 각 세션이 끝난 후 아카이브된 녹음이 제공될 예정입니다.
Bristol Myers Squibb (NYSE: BMY) a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025. L'entreprise participera à une discussion informelle lors de la 45ème Conférence Annuelle sur la Santé de TD Cowen le 4 mars 2025 à 14h30 ET. De plus, BMY participera à une autre discussion informelle lors de la Conférence Mondiale sur la Santé de Leerink Partners 2025 le 12 mars 2025 à 11h20 ET.
Les investisseurs et le grand public sont invités à écouter ces sessions en visitant le site web des relations investisseurs de l'entreprise à l'adresse http://investor.bms.com. Pour ceux qui ne peuvent pas assister en direct, des enregistrements archivés de chaque session seront mis à disposition après leur conclusion.
Bristol Myers Squibb (NYSE: BMY) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 bekannt gegeben. Das Unternehmen wird am 4. März 2025 um 14:30 Uhr ET an einem Fireside-Chat auf der TD Cowen 45. jährlichen Gesundheitskonferenz teilnehmen. Darüber hinaus wird BMY am 12. März 2025 um 11:20 Uhr ET an einem weiteren Fireside-Chat auf der Leerink Partners 2025 Global Healthcare Conference teilnehmen.
Sowohl Investoren als auch die allgemeine Öffentlichkeit sind eingeladen, diese Sitzungen zu hören, indem sie die Investor-Relations-Website des Unternehmens unter http://investor.bms.com besuchen. Für diejenigen, die nicht live teilnehmen können, werden nach Abschluss jeder Sitzung archivierte Aufzeichnungen zur Verfügung gestellt.
- None.
- None.
The company will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 2:30 p.m. ET. In addition, the company will take part in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on March 12, 2025, at 11:20 a.m. ET.
Investors and the general public are invited to listen to both sessions at their respective times by visiting http://investor.bms.com. An archived edition of each session will be available following its conclusion.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225770037/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When will Bristol Myers Squibb (BMY) present at the TD Cowen Health Care Conference in 2025?
What investor conferences will BMY attend in March 2025?
How can investors listen to BMY's presentations at the March 2025 conferences?
What time is Bristol Myers Squibb's presentation at the Leerink Partners 2025 Global Healthcare Conference?
Will BMY's investor conference presentations in March 2025 be available for replay?
